Evommune (EVMN) financials · rev $13.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Evommune (EVMN) rev $13.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $13.0M | $7.00M |
| Operating Income | -$81.1M | -$70.0M |
| Net Income | -$68.9M | -$66.8M |
| EPS (Diluted) | -$11.22 | -$45.29 |
| Line | FY2025 |
|---|---|
| Total Assets | $224.9M |
| Current Assets | $153.5M |
| Cash & Equivalents | $44.1M |
| PP&E | $994.0K |
| Total Liabilities | $19.4M |
| Current Liabilities | $17.9M |
| Shareholders' Equity | $205.6M |
| Retained Earnings | -$221.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$76.4M | -$58.2M |
| CapEx | $235.0K | $88.0K |
| Investing Cash Flow | -$115.3M | -$3.99M |
| Financing Cash Flow | $220.8M | $49.4M |
| Net Change in Cash | $29.0M | -$12.8M |
| Free Cash Flow | -$76.7M | -$58.3M |
FAQ
What is EVMN P/E and revenue?
Evommune (EVMN) rev $13.0M.
What is EVMN revenue?
Evommune last cached revenue is $13.0M (FY2025).
Is EVMN profitable?
Evommune last cached net income is -$68.9M (FY2025).
What are EVMN total assets?
Evommune last cached total assets are $224.9M (FY2025).
What is EVMN free cash flow?
Evommune last cached free cash flow is -$76.7M (FY2025).
Not investment advice. Cached statements, not a live tape.